rs231774

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000696479.1(CTLA4):​c.48-418T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.962 in 152,298 control chromosomes in the GnomAD database, including 70,709 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). The gene CTLA4 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.96 ( 70709 hom., cov: 31)

Consequence

CTLA4
ENST00000696479.1 intron

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0490

Publications

7 publications found
Variant links:
Genes affected
CTLA4 (HGNC:2505): (cytotoxic T-lymphocyte associated protein 4) This gene is a member of the immunoglobulin superfamily and encodes a protein which transmits an inhibitory signal to T cells. The protein contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases. [provided by RefSeq, Jul 2008]
CTLA4 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000696479.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 2-203867500-T-A is Benign according to our data. Variant chr2-203867500-T-A is described in ClinVar as Benign. ClinVar VariationId is 1261285.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000696479.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTLA4
ENST00000696479.1
c.48-418T>A
intron
N/AENSP00000512655.1A0A8Q3SIR7

Frequencies

GnomAD3 genomes
AF:
0.962
AC:
146397
AN:
152180
Hom.:
70663
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.870
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.984
Gnomad ASJ
AF:
0.986
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.997
Gnomad NFE
AF:
0.999
Gnomad OTH
AF:
0.974
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.962
AC:
146502
AN:
152298
Hom.:
70709
Cov.:
31
AF XY:
0.963
AC XY:
71681
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.870
AC:
36133
AN:
41534
American (AMR)
AF:
0.984
AC:
15065
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.986
AC:
3425
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5188
AN:
5188
South Asian (SAS)
AF:
0.999
AC:
4804
AN:
4808
European-Finnish (FIN)
AF:
1.00
AC:
10622
AN:
10622
Middle Eastern (MID)
AF:
0.997
AC:
293
AN:
294
European-Non Finnish (NFE)
AF:
0.999
AC:
67999
AN:
68040
Other (OTH)
AF:
0.974
AC:
2061
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
261
522
784
1045
1306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.975
Hom.:
9009
Bravo
AF:
0.956
Asia WGS
AF:
0.991
AC:
3448
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
2.7
DANN
Benign
0.75
PhyloP100
-0.049
PromoterAI
-0.0018
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs231774;
hg19: chr2-204732223;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.